Insufficient scRNA-seq data for expression of NLRX1 at single-cell level.
Insufficient scRNA-seq data for expression of NLRX1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3705.70 | 1445 / 1445 | 100% | 22.05 | 183 / 183 |
thymus | 100% | 1609.47 | 653 / 653 | 100% | 21.30 | 604 / 605 |
prostate | 100% | 1634.35 | 245 / 245 | 100% | 20.83 | 501 / 502 |
kidney | 100% | 1324.82 | 89 / 89 | 100% | 19.02 | 898 / 901 |
pancreas | 99% | 847.66 | 325 / 328 | 100% | 15.74 | 178 / 178 |
uterus | 100% | 1617.52 | 170 / 170 | 99% | 15.95 | 453 / 459 |
intestine | 100% | 1606.54 | 965 / 966 | 99% | 12.23 | 520 / 527 |
bladder | 100% | 1774.33 | 21 / 21 | 98% | 14.77 | 493 / 504 |
breast | 100% | 1362.10 | 458 / 459 | 98% | 12.17 | 1095 / 1118 |
skin | 100% | 2784.58 | 1809 / 1809 | 98% | 16.87 | 461 / 472 |
stomach | 99% | 1113.99 | 355 / 359 | 98% | 11.96 | 279 / 286 |
adrenal gland | 100% | 1887.52 | 258 / 258 | 95% | 11.15 | 218 / 230 |
lung | 95% | 1090.73 | 551 / 578 | 99% | 16.96 | 1147 / 1155 |
liver | 98% | 853.91 | 221 / 226 | 96% | 10.30 | 391 / 406 |
brain | 93% | 628.19 | 2464 / 2642 | 100% | 15.66 | 703 / 705 |
ovary | 94% | 723.70 | 169 / 180 | 98% | 14.81 | 421 / 430 |
eye | 0% | 0 | 0 / 0 | 100% | 30.06 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.15 | 29 / 29 |
spleen | 100% | 1502.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.95 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.56 | 1 / 1 |
muscle | 100% | 1941.20 | 802 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 1334.31 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1359.86 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1666.28 | 844 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 1632.31 | 823 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0010936 | Biological process | negative regulation of macrophage cytokine production |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0039536 | Biological process | negative regulation of RIG-I signaling pathway |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0045087 | Biological process | innate immune response |
GO_0032688 | Biological process | negative regulation of interferon-beta production |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NLRX1 |
Protein name | NLR family member X1 (Caterpiller protein 11.3) (CLR11.3) (Nucleotide-binding oligomerization domain protein 5) (Nucleotide-binding oligomerization domain protein 9) NLR family member X1 (NOD9 protein, isoform CRA_c) NLR family member X1 |
Synonyms | NOD5 hCG_38441 NOD9 |
Description | FUNCTION: Participates in antiviral signaling. Acts as a negative regulator of MAVS-mediated antiviral responses, through the inhibition of the virus-induced RLH (RIG-like helicase)-MAVS interaction . Instead, promotes autophagy by interacting with TUFM and subsequently recruiting the autophagy-related proteins ATG5 and ATG12 . Regulates also MAVS-dependent NLRP3 inflammasome activation to attenuate apoptosis . Has no inhibitory function on NF-kappa-B signaling pathway, but enhances NF-kappa-B and JUN N-terminal kinase dependent signaling through the production of reactive oxygen species . Regulates viral mediated-inflammation and energy metabolism in a sex-dependent manner (By similarity). In females, prevents uncontrolled inflammation and energy metabolism and thus, may contribute to the sex differences observed in infectious and inflammatory diseases (By similarity). . |
Accessions | ENST00000454811.5 ENST00000292199.6 [Q86UT6-1] ENST00000706729.1 [Q86UT6-1] C9JQE9 C9JLK8 ENST00000409991.5 [Q86UT6-1] ENST00000409109.6 [Q86UT6-1] ENST00000525863.1 [Q86UT6-2] ENST00000706728.1 A0A9L9PX86 Q86UT6 C9J0R6 ENST00000449394.5 ENST00000474751.7 ENST00000706727.1 ENST00000422249.5 A0A9L9PXS9 |